SERA (Sera Prognostics) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


SERA Sera Prognostics Inc SERA
70 GF Score
Price $1.84
GF Value $1.86
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Sera Prognostics Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Sera Prognostics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

SERA vs ECOR, OM, RTGN: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, Sera Prognostics's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sera Prognostics Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sera Prognostics's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Sera Prognostics's Margin of Safety % (DCF FCF Based) falls into.


SERA
70GF Score
Sera Prognostics Inc SERA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sera Prognostics (SERA) Overvalued in 2026?

Based on GuruFocus' analysis, Sera Prognostics stock appears to be undervalued. The current stock price of $1.84 is trading 1.1% below its estimated GF Value™ of $1.86. GuruFocus considers Sera Prognostics to be Fairly Valued.

Key valuation signals for SERA:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $1.86 vs. price of $1.84 (1.1% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the SERA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sera Prognostics Business Description

Address 2749 East Parleys Way, Suite 200, Salt Lake City, UT, USA, 84109
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
70GF Score

Get the complete analysis for SERA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.84
Price
$1.86
GF Value